# reload+after+2024-01-20 02:48:05.289394
address1§5 Badner Street
city§Ramat Gan
zip§5218102
country§Israel
phone§972 3 611 6600
fax§972 9 951 9708
website§https://www.xtlbio.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. Its lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Shlomo Spokone Shalev', 'age': 61, 'title': 'CEO & Director', 'yearBorn': 1962, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Itay  Weinstein', 'age': 52, 'title': 'Chief Financial Officer', 'yearBorn': 1971, 'exercisedValue': 0, 'unexercisedValue': 0}]
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.952
currency§USD
dateShortInterest§1702598400
exchange§NCM
quoteType§EQUITY
shortName§XTL Biopharmaceuticals Ltd.
longName§XTL Biopharmaceuticals Ltd.
firstTradeDateEpochUtc§1125581400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§2bfaf900-ccf9-390e-8b7d-2a1fb22696cd
gmtOffSetMilliseconds§-18000000
recommendationKey§none
quickRatio§13.617
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
